Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.
| Metric | CERT | GSK | ECILC | SNZ | MSB | BHC | Ind. Median |
|---|---|---|---|---|---|---|---|
| P/E | — | 14.08 | — | 5.76● | — | — | 41.96 |
| P/B | 1.08 | 4.60 | 0.80 | 0.45 | — | -0.88● | 2.50 |
| EV/EBITDA | 12.35 | 8.45 | 33.84 | 20.11 | — | 4.05● | 16.12 |
| P/S | 2.62 | 2.50 | 5.03 | 4.15 | 31.61 | 0.21● | 2.35 |
| Metric | CERT | GSK | ECILC | SNZ | MSB | BHC | Ind. Median |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.88● | 0.79 | 1.73 | 0.34 | — | 1.32 | 1.83 |
| Debt/Equity | 29.5% | 106.7% | 5.9% | 59.6% | — | -1,010.0%● | 22.0% |
| NetDebt/EBITDA | 1.49 | 1.35 | -0.10● | 11.44 | — | 3.71 | -0.01 |
| Metric | CERT | SDGR | HSTM | TDOC | PHR | MDRX | Ind. Median |
|---|---|---|---|---|---|---|---|
| P/E | — | — | 41.96● | — | 73.91 | — | 41.96 |
| P/B | 1.08● | 3.98 | 2.37 | 1.23 | 1.89 | — | 2.50 |
| EV/EBITDA | 12.35 | — | 11.21● | 33.77 | 16.42 | — | 16.12 |
| P/S | 2.62 | 4.90 | 2.68 | 0.66● | 1.37 | — | 2.35 |
| Metric | CERT | SDGR | HSTM | TDOC | PHR | MDRX | Ind. Median |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.88 | 2.74 | 0.97 | 2.80● | 1.76 | — | 1.83 |
| Debt/Equity | 29.5% | 34.1% | 4.0%● | 77.7% | 25.8% | — | 22.0% |
| NetDebt/EBITDA | 1.49 | 3.09 | -0.75● | 5.01 | 0.42 | — | -0.01 |
The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.
Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.